January 15 2008: 3:45 PM EST
Email | Print    Type Size  -  +

Here come the clones

The FDA has paved the way for a potential $20 billion market in cloned food products, overruling critics who say the full health effects are unknown.

By John Simons, writer

Bob and Karyn Schauf walk their cloned cow, Blackrose, 2, through a barn at their Barron, Wis., dairy farm.

WASHINGTON (Fortune) -- In a long-awaited and controversial decision, the Food and Drug Administration announced Tuesday that food products derived from cloned cattle, swine, goats, sheep and their offspring are safe enough to enter the U.S. food supply.

The agency is now expected to lift its ban on the sale of cloned food products, despite opposition from consumer groups questioning the long-term safety of consuming meat and milk from clones. Much to critics' dismay, the FDA has not mandated that food producers label products derived from cloned animals.

Executives at the two largest privately-held U.S. companies in the farm animal cloning business believe the ruling is a small, positive step in the age-old evolution of selective animal breeding. It also opens up a potential $20 billion market for farm animal cloning.

Since 2001, the FDA has maintained a voluntary moratorium on cloning livestock for the U.S. food supply. The ban gave the agency's researchers time to conduct tests and gather safety data on the effects of consuming meat and dairy produced by cloned animals or their progeny. In late 2006, the FDA released a draft of its animal clone safety assessment, concluding that "meat and milk from clones of adult cattle, pigs, goats and their offspring are as safe to eat as food from conventionally bred animals."

FDA officials say their assessment has been peer-reviewed by a number of independent cloning and animal health experts, who agree that livestock cloning is not only safe, but also "poses no unique risks to animal health when compared to other assistive reproductive technologies currently in use in U.S. agriculture," said Stephen Sundlof, director of FDA's center for veterinary medicine, in a 2006 statement. The U.S. agency is not alone in its endorsement of cloning. The FDA's European Union counterpart, as well as regulators in Australia and New Zealand, have made similar approvals.

Tuesday's safety ruling is accompanied by a set of FDA cloning process guidelines and standards to be used by farmers, livestock breeders and scientists. But is the American public ready for cloned food? In a recent Pew Research poll, more than 64 percent of Americans are uncomfortable with animal cloning and 43 percent say they believe food from cloned animals is unsafe.

Executives at companies involved in the animal cloning business admit they are battling great opposition. Much of the resistance, cloners believe, is founded on a number of misconceptions. "There's a tremendous lack of knowledge about the technology," Mark Walton, president and CEO of ViaGen, an Austin, Texas-based gene bank and cloning service founded in 2002. "Much of what people have heard about cloning is from sci-fi and horror movies. And the hero is never a clone."

Perhaps the biggest misconception about livestock cloning is that clones are animals that have been genetically modified. They are not. Clones are unaltered genetic copies. "What cloning allows some ranchers to do is replicate their best animals to achieve more consistent quality traits," says Karen Batra, a spokesperson for the National Cattlemen's Beef Association. "As breeders we're always looking for opportunities to give consumers better products. Whether it's more flavorful, less fatty, or more tender meat, consumers value that." Batra concedes that it will take a broad consumer education program to allay concerns.

Another erroneous, but widely held belief: The FDA's sanction means that consumers will be eating steak and drinking milk that comes directly from cloned cattle. ViaGen's Walton says this isn't likely, since his company charges farmers roughly $13,500 to produce a single cloned bull or cow. Says David Faber, president of Trans Ova Genetics: "These animals will be the rock stars of the barnyard. No one is interested in producing one of these to be eaten. They are simply breeding stock." Trans Ova, based in Sioux Center, Iowa, charges around $15,000 per cloned bull or cow.

Still, there is broad concern that the FDA doesn't know enough about the long-term health effects of consuming meat and milk from the progeny of clones. "It's a new technology and we don't think all the science is there," says Chris Waldrop, director of the Consumer Federation of America's Food Policy Institute. "We don't have enough information to make a decision."

Joseph Mendelson, legal director for Washington's Center for Food Safety agrees, adding that his organization has ethical and animal welfare concerns too. "It takes a number of attempts to make a clone. Some animals are born with deformities, or they're sick and have to be euthanized. Administrative agencies need to look at that."

Consumer groups aren't the only detractors of clone food products. Dean Foods (DF, Fortune 500), one of the country's biggest milk producers; Whole Foods (WFMI, Fortune 500); and ice-cream maker Ben & Jerry's have all said they won't sell milk or other products from cloned animals. Critics find it particularly worrisome that the FDA has said it won't require labeling for products of cloned animals and their offspring. The Department of Agriculture does however prevent meat and pork from the progeny of clones to be labeled organic.

Congress has expressed apprehension too. As part of the recent spending bill signed into law by President Bush, Congress urged the FDA not to act on the cloning matter until a full study had been conducted on the possible domestic and foreign trade implications.

In the meantime, ViaGen and Trans Ova Genetics are waiting for their big opportunity. These days, both companies eke out an existence cloning champion rodeo bulls, prize-winning pigs, and horses for equestrian event breeders (who pay as much as $150,000 for a perfect clone). "It's a small market now," says ViaGen's Mark Walton. "But FDA's rules will really open this market up. I see it becoming at least a $20 billion business worldwide."

Would Walton feed meat or pork from offspring of clones to his family? "I have," says Walton. "We had loins from the progeny of cloned boars in the freezer here at ViaGen. I took some home and cooked it. And you can't tell it apart." Soon, it will be the American consumer's turn to decide. To top of page

Company Price Change % Change
Ford Motor Co 8.29 0.05 0.61%
Advanced Micro Devic... 54.59 0.70 1.30%
Cisco Systems Inc 47.49 -2.44 -4.89%
General Electric Co 13.00 -0.16 -1.22%
Kraft Heinz Co 27.84 -2.20 -7.32%
Data as of 2:44pm ET
Index Last Change % Change
Dow 32,627.97 -234.33 -0.71%
Nasdaq 13,215.24 99.07 0.76%
S&P 500 3,913.10 -2.36 -0.06%
Treasuries 1.73 0.00 0.12%
Data as of 6:29am ET

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.